← Home
🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
Straumann Group
-4.8%
Healthcare & biotech / Dental Implants and Oral Regeneration
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebCore Facts
CEO | Mr. Guillaume Daniellot |
Employees | 11342 |
Phone | 41 61 965 11 11 |
Address | Peter Merian-Weg 12 Basel 04002 CH |
IPO Date | 2014-12-19 |
Average Volumes | 67740 |
Market Cap | 16.902 bil USD |
Div >7% since | N/A |
Web | https://www.straumann.com/group/de/de/startseite.html |
ISIN | CH1175448666 |
NASDAQ ticker | SAUHY |
News on YouTube | YouTube |
SEC | 'Straumann Group' on SEC |
Reports | 'Straumann Group' Reports |
CUSIP | 86317T103 |
Wait! There's more — sign up for free or log in